Literature DB >> 12883968

Focal segmental membranoproliferative glomerulonephritis in children.

Kikuo Iitaka1, Shinya Nakamura, Shunsuke Moriya, Osamu Motoyama, Tadasu Sakai.   

Abstract

Eight patients with focal segmental membranoproliferative glomerulonephritis (FSMPGN) were followed for 5-16 years. Their urinary abnormalities were detected by school urinary screening in seven, and one patient presented with nephrotic syndrome. All but one patient were treated with alternate-day (ALD) prednisolone. With time, urinalysis became normal in six and two continued to have proteinuria with or without hematuria. Serum albumin, cholesterol, and creatinine levels were normal at the last follow-up. Serum C3 returned to normal levels in six, but remained persistently decreased in two. Mesangial proliferation and matrix changes in glomeruli without MPGN lesions were mild. Subendothelial and mesangial electron-dense deposits and deposits containing C3 along capillary walls and mesangium were observed. MPGN lesions and mesangial proliferation improved. No severe growth retardation was observed, but the duration and dosage of ALD prednisolone could be reduced further, since the patients with FSMPGN seemed to have an excellent prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883968     DOI: 10.1007/s00467-003-1231-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  6 in total

1.  Decreasing hypocomplementemia and membranoproliferative glomerulonephritis in Japan.

Authors:  K Iitaka; T Saka; K Yagisawa; Y Aoki
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

2.  The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.

Authors:  P T McEnery; A J McAdams; C D West
Journal:  Medicine (Baltimore)       Date:  1985-11       Impact factor: 1.889

3.  Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.

Authors:  C F Strife; A J McAdams; C D West
Journal:  Clin Nephrol       Date:  1982-07       Impact factor: 0.975

4.  Focal and diffuse membranoproliferative glomerulonephritis in children.

Authors:  N Yoshikawa; S Yoshiara; K Yoshiya; T Matsuo; S Matsuyama; S Okada
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

5.  Membranoproliferative glomerulonephritis type I in children: correlation of clinical features with pathologic subtypes.

Authors:  A R Watson; S Poucell; P Thorner; G S Arbus; C P Rance; R Baumal
Journal:  Am J Kidney Dis       Date:  1984-09       Impact factor: 8.860

6.  Idiopathic membranoproliferative glomerulonephritis in Japanese children.

Authors:  K Iitaka; T Ishidate; M Hojo; S Kuwao; N Kasai; T Sakai
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  6 in total
  2 in total

1.  Two cases of atypical membranoproliferative glomerulonephritis showing opposite clinical course.

Authors:  Yuya Hashimura; Hiroshi Kaito; Kandai Nozu; Yuko Shima; Koichi Nakanishi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  CEN Case Rep       Date:  2012-04-10

2.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.